Sunday, November 7, 2021
- 8:30AM-10:30AM
-
Abstract Number: 0634
Correlation Between the Functional Component of the Multidimensional Health Assessment Questionnaire (FN), Modified Health Assessment Questionnaire (MHAQ), Health Assessment Questionnaire II (HAQ-II) and a Single Functional Question (PF) in Patients with Rheumatic Disease
Measures & Measurement of Healthcare Quality Poster (0623–0659)- 8:30AM-10:30AM
-
Abstract Number: 0882
COVID-19 Impact Among Patients with Systemic Lupus Erythematosus
SLE – Diagnosis, Manifestations, & Outcomes Poster II: Manifestations (0855–0896)- 8:30AM-10:30AM
-
Abstract Number: 0646
Dark Adaptometry Screening for Hydroxychloroquine Retinopathy: A Pilot Study
Measures & Measurement of Healthcare Quality Poster (0623–0659)- 8:30AM-10:30AM
-
Abstract Number: 0904
Data-driven Definitions Based on Inflammatory Lesions for a Positive MRI of the Spine Consistent with Axial Spondyloarthritis
Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster II: Imaging in Spondyloarthritis (0897–0907)- 8:30AM-10:30AM
-
Abstract Number: 0736
Decrease in Prevalence of Self-Reported Anxiety or Depression in Persons with Osteoarthritis After Total Knee Arthroplasty: The BEST KNEE Cohort Study
Osteoarthritis – Clinical Poster II (0723–0738)- 8:30AM-10:30AM
-
Abstract Number: 0775
Decreased HDL Levels and Antioxidant Function in Juvenile Dermatomyositis
Pediatric Rheumatology – Clinical Poster II: SLE, JDM, & Juvenile Scleroderma (0764–0785)- 8:30AM-10:30AM
-
Abstract Number: 0785
Decreased Peripheral Blood Natural Killer Cell Count in Untreated Juvenile Dermatomyositis Is Associated with Muscle Weakness
Pediatric Rheumatology – Clinical Poster II: SLE, JDM, & Juvenile Scleroderma (0764–0785)- 8:30AM-10:30AM
-
Abstract Number: 0655
Depression and Fatigue: Two Forgotten Associated Comorbidities in Patients with Rheumatoid Arthritis
Measures & Measurement of Healthcare Quality Poster (0623–0659)- 8:30AM-10:30AM
-
Abstract Number: 0890
Depression Is Associated with Frailty in Systemic Lupus Erythematosus Patients: Multicenter Retrospective Analysis Using Systemic Lupus Erythematosus International Collaborating Clinics-Frailty Index
SLE – Diagnosis, Manifestations, & Outcomes Poster II: Manifestations (0855–0896)- 8:30AM-10:30AM
-
Abstract Number: 0697
Detection of Autoantibodies Against Muscle-Specific Four-and-a-Half-LIM Domain 1 (FHL1) in Inflammatory Myopathies: Results from a Single-Center Cohort
Muscle Biology, Myositis & Myopathies Poster (0683–0722)- 8:30AM-10:30AM
-
Abstract Number: 0886
Determinants of Accessing Social and News Media and Experiencing Negative Impacts During COVID-19 in an International SLE Sample
SLE – Diagnosis, Manifestations, & Outcomes Poster II: Manifestations (0855–0896)- 8:30AM-10:30AM
-
Abstract Number: 0567
Determinants of Health-Related Quality of Life in Spondyloarthritis and Comparison with Chronic Low Back Pain – Results from a Nation-Wide Study
Epidemiology & Public Health Poster II: Inflammatory Arthritis – RA, SpA, & Gout (0560–0593)- 8:30AM-10:30AM
-
Abstract Number: 0532
Development of a Predictive Tool for the Rapid Progressive Knee Osteoarthritis Phenotype: Data from the Osteoarthritis Initiative
Genetics, Genomics & Proteomics Poster (0517–0533)- 8:30AM-10:30AM
-
Abstract Number: 0761
Development of a Symptom Diary for Use in Patients with Sjogren’s Syndrome